Skip to main content

Table 2 The serum levels of the hormones and metabolic profile, classified to 4 phenotypical groups and in non-PCOS women

From: The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran

Phenotype

A (n = 11)

B (n = 19)

C (n = 42)

D (n = 13)

E (n = 517)

Variables

AnOvu + HA + PCO

AnOvu + HA

HA + PCO

AnOvu + PCO

Normal

Testosterone (nmol/l)

0.4 ± 0.2

0.3 ± 0.4

0.2 ± 0.2

0.1 ± 0.1

0.1 ± 0.2

Androstendione (ng/ml)

3.7 ± 1.9

3.2 ± 2.1

2.0 ± 1.1

1.7 ± 0.7†‡

1.4 ± 0.9

DHEAS (μg/dl)

205.7 ± 79.6

188.7 ± 93.4

161.2 ± 81.5

116.7 ± 52.1†‡

119.7 ± 73.3

SHBG (nmol/l)

50.1 ± 39.62

49.7 ± 31.5

44.6 ± 30.2

54.4 ± 29.3

54.8 ± 34.9

FAI

2.8 ± 1.7

2.8 ± 2.6

2.3 ± 2.3

1.0 ± 1.0

1.2 ± 1.5

LH (μU/ml)

7.5 ± 5.9

7.8 ± 7.7

6.7 ± 5.4

6.0 ± 4.6

6.3 ± 5.9

FSH (μU/ml)

7.5 ± 1.17

8.4 ± 3.5

10.8 ± 12.0

8.3 ± 1.8

11.6 ± 10.0

Prolactin (ng/ml)

22.8 ± 12.0

19.9 ± 16.3

22.8 ± 15.3

23.4 ± 10.7

19.6 ± 20.0

TSH (μU/ml)

2.4 ± 1.3

2.4 ± 1.5

3.2 ± 2.7

1.8 ± 0.6

2.8 ± 2.7

Free T4 (picomol/l

15.7 ± 1.9

16.0 ± 3.4

15.7 ± 2.0

17.0 ± 2.6

15.5 ± 2.2

Insulin (μU/ml)

13.1 ± 10.6

7.7 ± 2.8

10.5 ± 13.0

5.7 ± 3.8†‡

9.7 ± 9.4

HOMA-IR

3.1 ± 2.7

1.7 ± 0.7

2.1 ± 1.8

1.2 ± 0.9†‡

2.5 ± 3.0

Cholesterol (mg/dl)

167.5 ± 35.8

159.4 ± 24.2

165.4 ± 40.2

156.5 ± 34.4

169.5 ± 34.4

HDL (mg/dl)

47.2 ± 9.8

49.4 ± 13.3

49.1 ± 11.0

46.4 ± 12.0

46.4 ± 11.9

LDL (mg/dl)

97.0 ± 30.5

89.2 ± 24.1

96.9 ± 39.2

93.1 ± 29.0

98.8 ± 29.5

Triglycerides (mg/dl)

116.3 ± 57.3

103.5 ± 49.5

98.0 ± 38.6

83.9 ± 40.1

122.6 ± 80.5

Glucose (mg/dl)

95.5 ± 7.8

94.1 ± 22.0

90.3 ± 11.8

87.5 ± 7.6

100.3 ± 48.0

  1. All analyses by ANCOVA adjusted for age and BMI.
  2. versus group E, P < 0.05.
  3. versus group A, P < 0.05.
  4. versus group C, P < 0.05.